Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 36: 800-804, 1990;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tikanoja, S. H.
Right arrow Articles by Liewendahl, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tikanoja, S. H.
Right arrow Articles by Liewendahl, B. K.

Clinical Chemistry, Vol 36, 800-804, Copyright © 1990 by American Association for Clinical Chemistry

New ultrafiltration method for free thyroxin compared with equilibrium dialysis in patients with thyroid dysfunction and nonthyroidal illness

SH Tikanoja and BK Liewendahl
Kuopio University Central Hospital, Finland.

This new ultrafiltration method for free thyroxin in serum [FT4(U)] is based on radioimmunoassay of the free hormone fraction in ultrafiltrates obtained by centrifuging serum samples in Unisep Ultracent-10 ultrafiltration devices. We compared the results obtained with those by an equilibrium dialysis method [FT4(D)]. In 36 euthyroid healthy subjects, the mean FT4(U) concentration was 24.2 pmol/L and the mean FT4(D) concentration 14.8 pmol/L. In hyperthyroid and hypothyroid patients, results by the ultrafiltration method were also approximately twice as high as those obtained by the dialysis method. In 23 patients with various nonthyroidal illnesses, mean FT4(U) was 41.2 pmol/L and mean FT4(D) 19.8 pmol/L. The mean FT4(U)/FT4(D) ratio in patients with nonthyroidal illnesses (1.97) was not significantly higher than in control subjects (1.68), making it unlikely that the increase in serum FT4 is caused by weakly protein-bound and therefore dialyzable inhibitors of thyroxin binding to carrier proteins. However, two nonthyroidally ill patients with a clearly increased FT4(U) but a normal FT4(D) concentration might have had such inhibitors, whereas for two other nonthyroidally ill patients a high molar ratio of free fatty acids to albumin is a more likely explanation for increased FT4(U) and FT4(D) concentrations. On theoretical grounds, we consider the FT4(U) concentrations analytically more nearly accurate than FT4(D) values for all patient groups studied.


The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
B. Yue, A. L. Rockwood, T. Sandrock, S. L. La'ulu, M. M. Kushnir, and A. W. Meikle
Free Thyroid Hormones in Serum by Direct Equilibrium Dialysis and Online Solid-Phase Extraction-Liquid Chromatography/Tandem Mass Spectrometry
Clin. Chem., April 1, 2008; 54(4): 642 - 651.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K. S. Fritz, R. M. Weiss, J. C. Nelson, and R. B. Wilcox
Unequal Concentrations of Free T3 and Free T4 after Ultrafiltration
Clin. Chem., July 1, 2007; 53(7): 1384 - 1385.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
K. S. Fritz, R. B. Wilcox, and J. C. Nelson
Quantifying Spurious Free T4 Results Attributable to Thyroxine-Binding Proteins in Serum Dialysates and Ultrafiltrates
Clin. Chem., May 1, 2007; 53(5): 985 - 988.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K. Van Uytfanghe, D. Stockl, H A. Ross, and L. M. Thienpont
Use of Frozen Sera for FT4 Standardization: Investigation by Equilibrium Dialysis Combined with Isotope Dilution-Mass Spectrometry and Immunoassay
Clin. Chem., September 1, 2006; 52(9): 1817 - 1821.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. S. Holm, L. Andreasen, S. H. Hansen, J. Faber, and P. Staun-Olsen
Influence of Adsorption and Deproteination on Potential Free Thyroxine Reference Methods
Clin. Chem., January 1, 2002; 48(1): 108 - 114.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
N. D. Christofides, E. Wilkinson, M. Stoddart, D. C. Ray, and G. J. Beckett
Assessment of Serum Thyroxine Binding Capacity-dependent Biases in Free Thyroxine Assays
Clin. Chem., April 1, 1999; 45(4): 520 - 525.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American Association for Clinical Chemistry.